RUSSIALINK: “Elderly Coronavirus Vaccine Recipients ‘Healthy,’ Russian Developer Says” – Moscow Times

File Photo of Blue-Gloved Hand Holding Syringe and Injecting Arm, adapted from image at nih.gov

(Moscow Times – themoscowtimes.com – Sept. 2, 2020) Elderly scientists who helped develop Russia’s Sputnik V coronavirus vaccine have not reported adverse effects after being injected, the head of the research institute behind the inoculation told the state-run RIA Novosti news agency Wednesday. Sputnik V’s registration last month as the world’s first coronavirus vaccine before large-scale clinical trials has sparked […]

» Read more

RUSSIALINK: “Covid-19 mass vaccination in Russia may start in Dec.-Jan. – Gamaleya Center director” – Interfax

Medical Symbol with Pole, Serpents, Wings, adapted from image at lanl.gov

A Covid-19 mass vaccination campaign may start in Russia in December-January, Alexander Gintsburg, director of the Gamaleya National Research Center for Epidemiology and Microbiology of the Russian Health Ministry, said […]

» Read more

JRL NEWSWATCH: “Russia Registers World’s First Covid-19 Vaccine Despite Safety Concerns” – Wall Street Journal/ Thomas Grove

Coronavirus File Photo adapted from image at cdc.gov

“Officials in Russia and the West express alarm at the speed the vaccine was developed.” “[With Putin’s blessing,] Russia registered the world’s first Covid-19 vaccine … amid [anticipation, skepticism and ] safety concerns …. Moscow’s [state-run] Gamaleya Institute for Epidemiology and Microbiology developed the vaccine … [with] military testing, accelerated clinical evaluations and shortened trial times …. Russia [plans] … […]

» Read more

JRL NEWSWATCH: “Industry Body Calls Russian Covid-19 Vaccine a Pandora’s Box” – Bloomberg/ Ilya Arkhipov, Jake Rudnitsky

Coronavirus File Photo adapted from image at cdc.gov

“Russia’s race to allow civilian use of a … coronavirus vaccine before clinical trials are complete could put people at risk, according to a local association of multinational pharmaceutical companies[, the Association of Clinical Trials Organizations (ACTO) … represent[ing] … multinational companies with clinical trials in Russia, including Pfizer, AstraZeneca and Novartis AG]. The government plans to give a vaccine […]

» Read more

JRL NEWSWATCH: “Russian COVID-19 Vaccine Approval Imminent, Source Says” – Reuters

Medical Symbol with Pole, Serpents, Wings, adapted from image at lanl.gov

“Russia’s first potential COVID-19 vaccine [reportedly] will win local regulatory approval in the first half of August and be administered to frontline health workers soon afterwards …. [Moscow] state research facility … Gamaleya Institute [] completed early human trials of the adenovirus-based vaccine this month and expects to begin large-scale trials in August. … The speed at which Russia is […]

» Read more